<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Eva M Goetz on McKennaLab</title>
    <link>https://mckennalab.org/authors/eva-m-goetz/</link>
    <description>Recent content in Eva M Goetz on McKennaLab</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 01 Jan 2015 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="https://mckennalab.org/authors/eva-m-goetz/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Genomic correlate of exceptional erlotinib response in head and neck squamous cell carcinoma</title>
      <link>https://mckennalab.org/publication/van-2015-genomic/</link>
      <pubDate>Thu, 01 Jan 2015 00:00:00 +0000</pubDate>
      
      <guid>https://mckennalab.org/publication/van-2015-genomic/</guid>
      <description></description>
    </item>
    
    <item>
      <title>MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition</title>
      <link>https://mckennalab.org/publication/wagle-2014-map/</link>
      <pubDate>Wed, 01 Jan 2014 00:00:00 +0000</pubDate>
      
      <guid>https://mckennalab.org/publication/wagle-2014-map/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma</title>
      <link>https://mckennalab.org/publication/van-2014-genetic/</link>
      <pubDate>Wed, 01 Jan 2014 00:00:00 +0000</pubDate>
      
      <guid>https://mckennalab.org/publication/van-2014-genetic/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
